Cyclophosphamide and Erythromycin ethylsuccinate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Cyclophosphamide and Erythromycin ethylsuccinate together.
The phase IV clinical study analyzes what interactions people who take Cyclophosphamide and Erythromycin ethylsuccinate have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Cyclophosphamide and Erythromycin ethylsuccinate together, and have interactions are studied.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 149,590 Cyclophosphamide users for its effectiveness, alternative drugs and more.
What is Erythromycin ethylsuccinate?
Erythromycin ethylsuccinate has active ingredients of erythromycin ethylsuccinate. eHealthMe is studying from 494 Erythromycin ethylsuccinate users for its effectiveness, alternative drugs and more.
Number of Cyclophosphamide and Erythromycin ethylsuccinate reports submitted per year:
Common Cyclophosphamide and Erythromycin Ethylsuccinate drug interactions by gender *:
female:
- Blood phosphorus decreased
male:
- Anaemia
- C-reactive protein increased
- Ear pain
- Febrile bone marrow aplasia
- Febrile neutropenia
- Throat irritation
Common Cyclophosphamide and Erythromycin Ethylsuccinate drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Anaemia
- C-reactive protein increased
- Ear pain
- Febrile bone marrow aplasia
- Febrile neutropenia
- Throat irritation
30-39:
n/a
40-49:
- Blood phosphorus decreased
50-59:
n/a
60+:
n/a
* Approximation only. Some reports may have incomplete information.
Do you take Cyclophosphamide and Erythromycin ethylsuccinate?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Cyclophosphamide (149,590 reports)
- Erythromycin ethylsuccinate (494 reports)
Browse all drug interactions of Cyclophosphamide and Erythromycin ethylsuccinate:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cyclophosphamide side effects:
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10,824 reports
- Fever: 9,920 reports
- Thrombocytopenia (decrease of platelets in blood): 9,104 reports
- Pneumonia: 7,306 reports
- Drug ineffective: 6,116 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 5,662 reports
- Diarrhea: 5,174 reports
Browse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cyclophosphamide interactions:
- Cyclophosphamide and Prednisone: 37,455 reports
- Cyclophosphamide and Methotrexate: 26,534 reports
- Cyclophosphamide and Etoposide: 24,104 reports
- Cyclophosphamide and Prednisolone: 20,265 reports
- Cyclophosphamide and Cytarabine: 18,102 reports
- Cyclophosphamide and Fludara: 17,751 reports
- Cyclophosphamide and Vincristine sulfate: 14,542 reports
- Cyclophosphamide and Dexamethasone: 11,626 reports
- Cyclophosphamide and Doxorubicin hydrochloride: 10,640 reports
- Cyclophosphamide and Cisplatin: 8,522 reports
Browse all interactions between Cyclophosphamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cyclophosphamide and erythromycin ethylsuccinate (the active ingredients of Cyclophosphamide and Erythromycin ethylsuccinate, respectively), and Cyclophosphamide and Erythromycin ethylsuccinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cyclophosphamide and Erythromycin ethylsuccinate.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Optic Neuropathy and drugs of ingredients of denosumab - now
- Wixela Inhub and Pain In Extremity - 2 seconds ago
- Celebrex and Microangiopathic Haemolytic Anaemia - 14 seconds ago
- Naloxone and Cholestasis - 15 seconds ago
- Inflammation and Hyporeflexia - 21 seconds ago
- Naloxone and Eyes - Bulging - 23 seconds ago
- Depression and Hypotension Aggravated - 25 seconds ago
- Levocarnitine and Electrocardiogram St Segment Elevation - 27 seconds ago
- Uroxatral and Mycoplasma Infection - 38 seconds ago
- Crohn'S Disease Aggravated and Metapneumovirus Infection - 43 seconds ago